Research: 2026-10-31
New Research Exposes the True Cost of Medicare in 2026: What Beneficiaries Actually Pay

On October 31, 2026, the Kaiser Family Foundation released its annual Medicare beneficiary cost analysis, and the numbers reveal a complicated picture for American seniors. The research, which examined spending data from over 42 million Medicare fee-for-service beneficiaries and 31 million Medicare Advantage enrollees, found that the average retiree now spends $6,800 out-of-pocket annually on premiums, deductibles, and coinsurance combined. For beneficiaries with three or more chronic conditions, that figure jumps to $11,400 per year. The report arrives just as the Medicare open enrollment period enters its final weeks, giving seniors a data-driven foundation for evaluating their current coverage. With Medicare Part B standard premiums holding at $185 per month in 2026 but deductibles shifting upward, understanding where your money goes has never been more important. This article breaks down the specific findings from the October research release and shows you exactly how to apply them to your personal Medicare situation.
Part B Premiums and Deductibles in 2026
In 2026, the standard Medicare Part B premium remains set at $185 per month for most beneficiaries, a figure that translates to $2,220 over the full calendar year. However, the annual Part B deductible has increased by $18 from the previous year, now standing at $257 before Medicare begins covering its 80 percent share of outpatient services. For seniors who visit specialists regularly or require quarterly blood work, these deductible resets create predictable but significant out-of-pocket obligations. A beneficiary with rheumatoid arthritis who sees their specialist every eight weeks and requires monthly lab panels can expect to hit the Part B deductible by early March. Once the deductible is satisfied, the 20 percent coinsurance still applies to all outpatient services, meaning a $350 specialist visit leaves the patient responsible for $70 out of pocket. Over a twelve-month period, a typical beneficiary with moderate medical needs accumulates approximately $1,840 in coinsurance payments after meeting the deductible. The research found that beneficiaries who fail to budget for both the premium and the deductible upfront often experience cash flow disruptions during the first quarter of the year. Understanding that the $185 premium is only the starting point helps set realistic expectations for total Part B costs.
The Part D Out-of-Pocket Cap Finally Arrives
The 2026 plan year marks the first full implementation of the $2,000 annual out-of-pocket prescription drug spending cap established by the Inflation Reduction Act. Prior to this change, beneficiaries with high-cost medications could face unlimited 5 percent coinsurance after reaching the catastrophic coverage threshold. The new research reveals that approximately 3.2 million Medicare beneficiaries will hit the $2,000 cap during 2026, with the average beneficiary who reaches the cap doing so by July 14. For patients taking specialty medications such as cancer immunotherapy drugs, which can retail for $12,000 to $15,000 per month, the cap represents a transformative financial protection. A leukemia patient taking dasatinib, priced at roughly $13,400 monthly, previously faced annual out-of-pocket costs exceeding $7,000. Under the new cap, their maximum exposure is now $2,000. However, the research notes that many beneficiaries confuse the cap with eliminating costs altogether. Monthly premiums for Part D plans still apply, averaging $42 per month in 2026, and the cap does not apply to premiums or medications excluded from formularies. Beneficiaries must also remain in their chosen plan for the full year to benefit from the cap structure, making plan selection during open enrollment a critical financial decision.
Medicare Advantage Enrollment Hits a Ceiling
For the first time in two decades, Medicare Advantage enrollment growth slowed to single digits in 2026, with total participation reaching 32.8 million beneficiaries or roughly 51 percent of the Medicare population. The October research attributes this plateau to several factors, including tighter network restrictions and rising scrutiny of prior authorization denials. In 2026, the average Medicare Advantage enrollee faced restricted access to 34 percent of oncology specialists within a 25-mile radius, compared to unrestricted Original Medicare. The research also found that beneficiaries switching from Medicare Advantage back to Original Medicare increased by 12 percent year-over-year, with unexpected out-of-network costs cited as the primary driver. A 68-year-old retiree in Florida who enrolled in a zero-premium Medicare Advantage plan discovered that her preferred orthopedic surgeon was out of network, resulting in a $14,000 bill for a knee replacement that would have cost her $1,840 under Original Medicare with a Medigap plan. Despite these concerns, Medicare Advantage plans continue to offer supplemental benefits like dental and vision coverage that Original Medicare does not provide. The average value of these extra benefits in 2026 is estimated at $312 annually per enrollee, though utilization rates remain low at just 41 percent.
Medigap Pricing Gaps Widen Between States
The October 31st research highlighted dramatic variation in Medigap plan premiums across state lines, with identical Plan G policies showing price differentials of over 300 percent. In 2026, the national average monthly premium for a 65-year-old non-smoker purchasing Plan G was $198, but beneficiaries in New York faced average premiums of $325 while those in North Carolina paid an average of $142 for identical standardized benefits. The disparity stems from state-specific rating methods and local healthcare costs. Community-rated states like New York prohibit age-based pricing, which ironically drives higher baseline premiums for new enrollees. In contrast, attained-age-rated states like Florida start lower but increase premiums as beneficiaries age, meaning a 75-year-old in Miami pays significantly more than the initial quoted price. The research identified that 28 percent of Medicare beneficiaries do not realize their Medigap premiums can increase over time, assuming the price is locked in like a term life insurance policy. For a married couple in Ohio switching from Plan N to Plan G, the annual cost difference amounts to $1,440 in premiums, yet Plan G eliminates all Part B excess charges while Plan N requires 20 percent coinsurance on emergency room visits. Understanding these state-level pricing mechanics prevents beneficiaries from overpaying for coverage they could obtain elsewhere at a lower cost.
Common Mistakes That Cost Beneficiaries Thousands
Despite abundant information, Medicare enrollees continue to make expensive errors that the October research quantified with hard data. The most costly mistake remains missing the Initial Enrollment Period, with approximately 740,000 Americans facing lifetime Part B premium penalties in 2026. These penalties add 10 percent to the monthly premium for every full twelve-month period of delayed enrollment, meaning someone who signs up three years late pays an additional $55.50 per month for life. Another frequent error involves ignoring the Part D late enrollment penalty, which in 2026 affects roughly 1.2 million beneficiaries who went without creditable prescription coverage. This penalty equals 1 percent of the national base beneficiary premium for each uncovered month, permanently increasing monthly costs. A third costly oversight is failing to review plan changes during open enrollment. The research found that 62 percent of beneficiaries auto-renewed their Medicare Advantage plans without checking 2026 formulary changes, and 18 percent of those discovered a critical medication was dropped from coverage in January. One beneficiary in Texas continued paying a $67 monthly premium for a plan that removed her $8,400-per-year multiple sclerosis drug from its formulary, forcing her to pay the full retail price for three months before switching plans. Additionally, many seniors assume Medicare covers long-term care, only to learn after a hospitalization that skilled nursing facility coverage requires a preceding three-day inpatient stay and caps at 100 days with steep coinsurance after day 20.
How to Check Your Own Situation Against the Data
Applying the October research to your personal Medicare coverage requires systematic verification rather than guesswork. Start by logging into your Medicare.gov account and navigating to the Plan Finder tool to confirm your current plan's 2026 premium, deductible, and drug formulary. Compare your current Part D plan's total annual cost estimator against at least two alternative plans using your specific medication list. The research found that beneficiaries who comparison-shopped Part D plans saved an average of $612 annually compared to those who auto-enrolled. Next, request a Medicare Summary Notice from SocialSecurity.gov or check your mailed quarterly statements to verify whether you have been charged the standard Part B premium or an income-related adjusted amount. In 2026, individuals with modified adjusted gross incomes above $106,000 and couples above $212,000 fall into higher premium brackets. Review your Explanation of Benefits statements from any recent hospitalizations to confirm whether Medicare paid as primary insurance and whether your Medigap plan, if applicable, covered the expected coinsurance. If you are enrolled in Medicare Advantage, call your plan's customer service line and ask for the current prior authorization requirements and out-of-network cost-sharing limits for your most frequently used providers. Document these answers in writing. Finally, schedule a consultation with your State Health Insurance Assistance Program counselor, a free service available in every state, to review whether your current coverage aligns with the spending benchmarks identified in the October 31st research.
Hospital Stays and Part A Cost Surprises
Medicare Part A remains premium-free for beneficiaries with 40 or more quarters of covered employment, yet the October research revealed that hospitalization costs still catch many enrollees unprepared. In 2026, the Part A inpatient hospital deductible stands at $1,676 per benefit period, with coinsurance of $419 per day beginning on day 61 and increasing to $838 per day by day 91 when lifetime reserve days commence. The average Medicare beneficiary experiences 1.7 benefit periods annually, meaning a single hospitalization can trigger multiple deductible obligations if readmitted after 60 days. The research documented that 28 percent of hospitalized seniors were unaware that skilled nursing facility coverage requires a qualifying three-day inpatient hospital stay and covers only days 21 through 100 at a daily coinsurance rate of $209.50 in 2026. A common scenario involves a patient admitted for observation rather than as an inpatient, which does not satisfy the three-day requirement. One 72-year-old in Arizona spent two days in observation status for chest pain, was discharged to a skilled nursing facility for rehabilitation, and received a $18,400 bill because Medicare did not consider the observation stay a qualifying hospitalization. Beneficiaries can protect themselves by asking hospital physicians directly whether their status is inpatient or observation and requesting a formal determination if the answer is unclear.
IRMAA Brackets Capture More Seniors in 2026
The Income-Related Monthly Adjustment Amount affected approximately 8.5 million Medicare beneficiaries in 2026, up from 7.8 million the previous year, as inflation pushed more retirees into higher income brackets. The October research detailed the 2026 IRMAA tiers, which begin at modified adjusted gross incomes of $106,000 for individuals and $212,000 for married couples filing jointly. At the first tier, Part B premiums increase from $185 to $259 per month, while Part D premiums see an additional $13.20 monthly surcharge. At the highest tier, for individuals earning above $500,000 and couples above $750,000, the total monthly Part B premium reaches $578.70. The research noted a significant pain point for retirees who downsize homes or take large distributions from tax-deferred accounts. A retired couple in New Jersey who sold their home of thirty years realized a capital gain that pushed their MAGI above $300,000 for the year, triggering IRMAA surcharges that added $4,200 to their annual Medicare costs. Because IRMAA is based on tax returns from two years prior, newly retired seniors whose 2024 incomes were high but whose 2026 retirement incomes dropped may appeal the surcharge through Social Security. However, the research found that only 12 percent of eligible beneficiaries file appeals, leaving millions in unnecessary premium obligations. Beneficiaries experiencing a qualifying life-changing event such as marriage, divorce, death of a spouse, or reduction in work hours can request a new initial determination using Form SSA-44.
Chronic Condition Costs Drive Spending
The October research underscored that chronic disease management represents the largest share of Medicare beneficiary out-of-pocket spending. Beneficiaries with diabetes, congestive heart failure, chronic kidney disease, or COPD faced average annual out-of-pocket costs of $8,900 in 2026, compared to $3,200 for those without chronic conditions. For diabetic beneficiaries using insulin, the Inflation Reduction Act's $35 monthly insulin copay cap reduced average annual insulin spending from $1,270 to $420, yet ancillary costs such as glucose test strips, lancets, and podiatrist visits added an average of $1,840 annually. Kidney disease patients requiring dialysis encountered particularly steep costs despite Medicare coverage, with the average hemodialysis patient paying $5,600 out-of-pocket per year for transportation, specialty medications, and dietary supplements not covered under standard benefits. The research also identified that beneficiaries managing multiple chronic conditions visited an average of six different specialists annually, creating fragmented care and duplicate billing. A heart failure patient in Georgia saw three cardiologists, a nephrologist, an endocrinologist, and a pulmonologist within one calendar year, resulting in eight separate bills that exceeded $2,400 in combined Part B coinsurance after the deductible. The data suggests that coordinating care through a Medicare Advantage chronic special needs plan or a Medigap plan paired with a Medicare medical home model can reduce redundant testing and out-of-pocket expenses.
Preparing for the 2027 Enrollment Season
With open enrollment for 2027 coverage beginning October 15, 2026, the research emphasized proactive planning using current-year data. Premiums for 2027 are projected to increase by 3.8 percent on average for Part D plans and 2.4 percent for Medicare Advantage plans, based on early filings submitted to the Centers for Medicare and Medicaid Services. Beneficiaries currently enrolled in Original Medicare should obtain 2027 Medigap quotes by November 15 if they wish to switch plans, as some states restrict Medigap enrollment outside specific windows. Those considering Medicare Advantage should review the 2027 Star Ratings, expected for release in mid-October, which reflect plan quality and customer satisfaction on a five-point scale. Plans rated below 3.5 stars face sanctions and potential termination. The research recommended that beneficiaries create a written medication list including dosages and frequencies, then input this information into the Medicare Plan Finder to calculate total annual costs rather than relying on premium alone. A beneficiary taking four generic medications and one brand-name drug discovered that a $0-premium Medicare Advantage plan would cost her $1,840 more annually than a $28-per-month Part D plan paired with Medigap, solely due to formulary tier placement. The October 31st report concluded that beneficiaries who begin their review process by November 1 save an average of $340 compared to those who wait until the final week of open enrollment.
Conclusion and Next Steps
The October 31, 2026 Medicare cost research provides a clear financial roadmap for beneficiaries navigating an increasingly complex system. With verified data showing average out-of-pocket costs approaching $6,800 annually, informed decision-making during open enrollment directly impacts retirement savings and quality of care. Whether you are managing chronic conditions, anticipating a hospital stay, or simply reviewing your premiums, applying these research findings to your personal situation is the most effective step you can take before the 2027 enrollment deadlines pass.
If you are unsure whether your current plan still fits your health needs and budget, contact a licensed Medicare agent in your area who can run personalized quotes, verify provider networks, and identify programs that lower your prescription drug costs. A qualified agent understands the specific plans available in your county and can ensure you are not paying more than necessary for the coverage you deserve.
Get Matched with a Licensed Agent
Want personalized guidance? We'll connect you with a top-rated Medicare agent in your area.
Connect with an AgentAlso worth your inbox
Straight AEP — Annual Enrollment Period
Get it free →
Straight Retirement — Annuities & retirement income, plainly
Get it free →
Published 2026-11-10 12:12:48.882147+00:00
The Agent's Ledger — the weekly digital paper for agents
Training, compliance, sales, market trends, and leisure — 20+ pages, page-flip format. First month free.
Subscribe to The Agent's Ledger